Does XARELTO Cause Activated partial thromboplastin time prolonged? 13 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 13 reports of Activated partial thromboplastin time prolonged have been filed in association with XARELTO. This represents 0.4% of all adverse event reports for XARELTO.
13
Reports of Activated partial thromboplastin time prolonged with XARELTO
0.4%
of all XARELTO reports
1
Deaths
12
Hospitalizations
How Dangerous Is Activated partial thromboplastin time prolonged From XARELTO?
Of the 13 reports, 1 (7.7%) resulted in death, 12 (92.3%) required hospitalization.
Is Activated partial thromboplastin time prolonged Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for XARELTO. However, 13 reports have been filed with the FAERS database.
What Other Side Effects Does XARELTO Cause?
Pulmonary embolism (276)
Deep vein thrombosis (234)
Drug ineffective (199)
Gastrointestinal haemorrhage (198)
Cerebrovascular accident (180)
Haemoglobin decreased (166)
Fall (124)
Anaemia (123)
Haemorrhage (121)
Cerebral haemorrhage (110)
What Other Drugs Cause Activated partial thromboplastin time prolonged?
DABIGATRAN ETEXILATE (264)
HEPARIN (225)
RIVAROXABAN (163)
WARFARIN (146)
ACETAMINOPHEN (119)
ALLOPURINOL (110)
AMIODARONE (99)
METRONIDAZOLE (98)
SIMVASTATIN (94)
DARBEPOETIN ALFA (93)